DOTA-TATE(DOTA-[Tyr3]-Octreotate), precursor for radiolabeled DOTA-TATE and ligand for somatostatin receptors. Can be bound to radionuclides for development of cancer treatment and diagnosis. For research use only!
DOTA-TATE(DOTA-[Tyr3]-Octreotate) - Specifications
Amino acid sequence: DPhe-Cys-Tyr-DTrp-Lys-Thr-Cys-Thr (cyclic disulfide)
Amount: 5 mg (50 x100µg)
Purity: >95% (HPLC-MS)
Delivery Format: Freeze-dried in glass vial
Application(s): Nuclear medicine
Condition(s)/Topic(s): Cancer
Standard Delivery Time: approx. 3 weeks
Are you interested in your other radoligands? Choose your sequence, amount and purity. We will assist you along the way. Custom Peptide Synthesis.
JPT's Single Catalog Peptides
JPT Peptide Technologies has substantial, long-standing expertise in providing custom peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All of JPT's catalogue peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.
Benefits of JPT's Single Catalogue Peptides
- Whole production performed in a regulated European environment according to DIN EN ISO 9001:2015 & GCLP standards; audits welcome!
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies
![DOTA-TATE(DOTA-[Tyr3]-Octreotate)](https://media.jpt.com/Media/Images/Product_Fotos/DOTA-TATE(DOTA-[Tyr3]-Octreotate).jpg "DOTA-TATE(DOTA-[Tyr3]-Octreotate)")
![DOTA-TOC (DOTA-[Tyr3]-octreotide)](https://media.jpt.com/Media/Images/Product_Fotos/DOTA-TOC-(DOTA-[Tyr3]-octreotide).jpg "DOTA-TOC (DOTA-[Tyr3]-octreotide)")
![DOTA-NOC (DOTA-[Nal3]-octreotide)](https://media.jpt.com/Media/Images/Product_Fotos/DOTA-NOC-(DOTA-[Nal3]-octreotide).jpg "DOTA-NOC (DOTA-[Nal3]-octreotide)")